BI-764198 clinical trials
Also written BI 764198 and Apecotrep.
How each study uses BI-764198 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the BI-764198 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
13 studies that test it; most in 2026 (4)
| Year | Studies |
|---|---|
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 4 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 13 · Other 0
Studies
Open first, then newest update. How each study uses BI-764198 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 13
- A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)RecruitingPhase 3Boehringer IngelheimNCT07220083Written as BI 764198
- PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney DiseaseRecruitingPhase 2Boehringer IngelheimNCT07355296Written as BI 764198
- A Study in People With Normal Kidney Function and People With Reduced Kidney Function to Test How BI 764198 is Processed in the BodyCompletedPhase 1Boehringer IngelheimNCT04176536Written as BI 764198
- A Study in Healthy Men Tests How Different Doses of BI 764198 Are Taken up in the Body and How Well They Are Tolerated.CompletedPhase 1Boehringer IngelheimNCT03854552Written as BI 764198
- A Study in Healthy Men to Test if Different Formulations of BI 764198 With or Without Food Influence the Amount of BI 764198 in the BloodCompletedPhase 1Boehringer IngelheimNCT04656288Written as BI 764198 - Formula A
- A Study in Healthy People to Test How 3 Different Formulations of BI 764198 Are Taken up in the Body and How This is Influenced by FoodCompletedPhase 1Boehringer IngelheimNCT06955754Written as BI 764198, formulation 1
- A Study in Healthy People to Test Whether BI 764198 Influences the Amount of Metformin in the BodyCompletedPhase 1Boehringer IngelheimNCT07368569Written as BI 764198
- A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 764198 in the BloodCompletedPhase 1Boehringer IngelheimNCT07308652Written as BI 764198
- A Study in Healthy Men to Test How BI 764198 is Processed in the BodyCompletedPhase 1Boehringer IngelheimNCT05863130Written as BI 764198 (C-14) (approach 1)
- A Study to Test BI 764198 in People With a Type of Kidney Disease Called Focal Segmental GlomerulosclerosisCompletedPhase 2Boehringer IngelheimNCT05213624Written as BI 764198
- ACTION ON COVID-19: A Study to Test Whether BI 764198 Helps Lung Health of People Hospitalised With COVID-19TerminatedPhase 2Boehringer IngelheimNCT04604184Written as BI 764198
- A Study in Healthy Japanese Men to Test How Well Different Doses of BI 764198 Are ToleratedCompletedPhase 1Boehringer IngelheimNCT04665700Written as BI 764198
- A Study to Test How Well Healthy Men Tolerate Different Doses of BI 764198CompletedPhase 1Boehringer IngelheimNCT04102462Written as BI 764198